Direct cross-priming by Th lymphocytes generates memory cytotoxic T cell responses

Journal of Immunology

Volumn 174, Issue 7, 2005, Pages 3967-3977

  Kennedy, Richard ^a   Undale, Anita H ^a   Kieper, William C ^a   Block, Matthew S ^a   Pease, Larry R ^a   Celis, Esteban ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MEMORY CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION;

EID: 15444374364     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.7.3967     Document Type: Article

References (61)

1. Sun, J. C., and M. J. Bevan. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300:339.
2. + T lymphocytes. Nature 421:852.
3. + T cell memory. Science 297:2060.
4. Schoenberger, S. P., R. E. Toes, E. I. van der Voort, R. Offringa, and C. J. Melief. 1998. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480.
5. + T-helper and a T-killer cell. Nature 393:474.
6. Bennett, S. R., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signaling. Nature 393:478.
7. Sun, J. C., and M. J. Bevan. 2004. Cutting edge: long-lived CD8 memory and protective immunity in the absence of CD40 expression on CD8 T cells. J. Immunol. 172:3385.
8. Lee, B. O., L. Hartson, and T. D. Randall. 2003. CD40-deficient, influenza-specific CD8 memory T cells develop and function normally in a CD40-sufficient environment. J. Exp. Med. 198:1759.
9. Gravestein, L. A., and J. Borst. 1998. Tumor necrosis factor receptor family members in the immune system. Semin. Immunol. 10:423.
10. Sabzevari, H., J. Kantor, A. Jaigirdar, Y. Tagaya, M. Naramura, J. Hodge, J. Bernon, and J. Schlom. 2001. Acquisition of CD80 (B7-1) by T cells. J. Immunol. 166:2505.
11. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76:17.
12. lo thymocytes in vivo. Science 250:1720.
13. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76:34.
14. Nairn, R., K. Yamaga, and S. G. Nathenson. 1980. Biochemistry of the gene products from murine MHC mutants. Annu. Rev. Genet. 14:241.
15. + T-cell responses and tumor immunity. Blood 102:4137.
16. Porgador, A., J. W. Yewdell, Y. Deng, J. R. Bennink, and R. N. Germain. 1997. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6:715.
17. Davila, E., and E. Celis. 2000. Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity. J. Immunol. 165:539.
18. Pullen, J. K., H. D. Hunt, R. M. Horton, and L. R. Pease. 1989. The functional significance of two amino acid polymorphisms in the antigen-presenting domain of class I MHC molecules: molecular dissection of Kbm3. J. Immunol. 143:1674.
19. Lanzavecchia, A. 1985. Antigen-specific interaction between T and B cells. Nature 314:537.
20. Maecker, H. T., D. T. Umetsu, R. H. DeKruyff, and S. Levy. 1998. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC. J. Immunol. 161:6532.
21. Quinn, A., M. F. McInerney, and E. E. Sercarz. 2001. MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity. J. Immunol. 167:1748.
22. Durinovic-Bello, I. 1998. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens. Autoimmunity 27:159.
23. Wong, F. S., J. Karttunen, C. Dumont, L. Wen, I. Visintin, I. M. Pilip, N. Shastri, E. G. Pamer, and C. A. Janeway, Jr. 1999. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat. Med. 5:1026.
24. + T-cell epitope on rubella capsid protein. Virology 235:286.
25. + class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide. J. Immunol. 148:894.
26. Chisari, F. V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29.
27. Celis, E., D. Ou, and L. Otvos, Jr. 1988. Recognition of hepatitis B surface antigen by human T lymphocytes: proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides. J. Immunol. 140:1808.
28. Takeshita, T., H. Takahashi, S. Kozlowski, J. D. Ahlers, C. D. Pendleton, R. L. Moore, Y. Nakagawa, K. Yokomuro, B. S. Fox, and D. H. Margulies. 1995. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule. J. Immunol. 154:1973.
29. De Groot, A. S., M. Clerici, A. Hosmalin, S. H. Hughes, D. Barnd, C. W. Hendrix, R. Houghten, G. M. Shearer, and J. A. Berzofsky. 1991. Human immunodeficiency virus reverse transcriptase T helper epitopes identified in mice and humans: correlation with a cytotoxic T cell epitope. J. Infect. Dis. 164:1058.
30. + T lymphocytes against tumor cells bearing mutated epitopes of K-ras p21. Eur. J. Immunol. 25:2588.
31. + T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunization. Cell. Immunol. 205:73.
32. Grohmann, U., M. L. Belladonna, R. Bianchi, C. Orabona, S. Silla, G. Squillacioti, M. C. Fioretti, and P. Puccetti. 1999. Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex. Cancer Immunol. Immunother. 48:195.
33. Markiewicz, M. A., F. Fallarino, A. Ashikari, and T. F. Gajewski. 2001. Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide PIA. Int. Immunol. 13:625.
34. + T cells. Proc. Natl. Acad. Sci. USA 91:3171.
35. Gnjatic, S., D. Atanackovic, M. Matsuo, E. Jager, S. Y. Lee, D. Valmori, Y. T. Chen, G. Ritter, A. Knuth, and L. J. Old. 2003. Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCs. J. Immunol. 170:1191.
36. + T cells in the context of HLA-B51. Cancer Immunity 2:12.
37. Kobayashi, H., J. Lu, and E. Celis. 2001. Identification of helper T-cell epitopes that encompass or lie proximal to cytotoxic T-cell epitopes in the gp100 melanoma tumor antigen. Cancer Res. 61:7577.
38. Celis, E., J. J Goodwin, and T. A. Saibara. 1992. Peptide-induced proliferation and lymphokine production in human T cells in the absence of antigen-presenting cells: role of T-cell activation state and costimulatory signals. Hum. Immunol. 34:173.
39. Arnold, P. Y., D. K. Davidian, and M. D. Mannie. 1997. Antigen presentation by T cells: T cell receptor ligation promotes antigen acquisition from professional antigen-presenting cells. Eur. J. Immunol. 27:3198.
40. Mannie, M. D., S. K. Rendall, P. Y. Arnold, J. P. Nardella, and G. A. White. 1996. Anergy-associated T cell antigen presentation: a mechanism of infectious tolerance in experimental autoimmune encephalomyelitis. J. Immunol. 157:1062.
41. Mannie, M. D., G. A. White, J. P. Nardella, D. K. Davidian, and P. Y. Arnold. 1998. Partial agonism elicits an enduring phase of T-cell-medicated antigen presentation. Cell. Immunol. 186:83.
42. Huang, J. F., Y. Yang, H. Sepulveda, W. Shi, I. Hwang, P. A. Peterson, M. R. Jackson, J. Sprent, and Z. Cai. 1999. TCR-mediated internalization of peptide-MHC complexes acquired by T cells. Science 286:952.
43. Ziegler, S. F., F. Ramsdell, and M. R. Alderson. 1994. The activation antigen CD69. Stem Cells 12:456.
44. Lowenthal, J. W., C. Tougne, H. R. MacDonald, K. A. Smith, and M. Nabholz. 1985. Antigenic stimulation regulates the expression of TL 2 receptors in a cytolytic T lymphocyte clone. J. Immunol. 134:931.
45. Jung, T. M., W. M. Gallatin, I. L. Weissman, and M. O. Dailey. 1988. Down-regulation of homing receptors after T cell activation. J. Immunol. 141:4110.
46. Lanzavecchia, A., and F. Sallusto. 2000. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 290:92.
47. Sprent, J., and D. F. Tough. 1994. Lymphocyte life-span and memory. Science 265:1395.
48. + T cells to antigen stimulation in vivo. Nat. Immunol. 1:47.
49. + T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2:415.
50. + T cell turnover in vivo by IL-12, IL-18, and IFN-γ. J. Immunol. 166:6007.
51. Schluns, K. S., and L. Lefrancois. 2003. Cytokine control of memory T-cell development and survival. Nat. Rev. Immunol. 3:269.
52. + cells. J. Exp. Med. 195:1523.
53. Clarke, S. R., M. Barnden, C. Kurts, F. R. Carbone, J. F. Miller, and W. R. Heath. 2000. Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol. Cell Biol. 78:110.
54. Bevan, M. J. 1976. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143:1283.
55. Rock, K. L., S. Gamble, and L. Rothstein. 1990. Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science 249:918.
56. Zinkernagel, R. M. 2002. On cross-priming of MHC class I-specific CTL: rule or exception? Eur. J. Immunol. 32:2385.
57. Nag, B., S. V. Deshpande, S. D. Sharma, and B. R. Clark. 1993. Cloned T cells internalize peptide from bound complexes of peptide and purified class II major histocompatibility complex antigen. J. Biol. Chem. 268:14360.
58. Hwang, I., J. F. Huang, H. Kishimoto, A. Brunmark, P. A. Peterson, M. R. Jackson, C. D. Surh, Z. Cai, and J. Sprent. 2000. T cells can use either T cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen-presenting cells. J. Exp. Med. 191:1137.
59. Tse, D. B., and B. Pernis. 1984. Spontaneous internalization of class I major histocompatibility complex molecules in T lymphoid cells. J. Exp. Med. 159:193.
60. Gromme, M., F. G. Uytdehaag, H. Janssen, J. Calafat, R. S. van Binnendijk, M. J. Kenter, A. Tulp, D. Verwoerd, and J. Neefjes. 1999, Recycling MHC class I molecules and endosomal peptide loading. Proc. Natl. Acad. Sci. USA 96:10326.
61. + CTL in vivo with peptide vaccine constructs. J. Immunol. 152:549.